Richard S Levy Insider Trading $INCY INCYTE CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard S Levy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard S Levy. Richard S Levy is EVP, Chief Drug Dev Officer in INCYTE CORP ($INCY) and EVP, Chief Drug Dev&Medical Of in INCYTE CORP ($INCY) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in ArTara Therapeutics, Inc. ($PRTO) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Kodiak Sciences Inc. ($KOD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Richard S Levy in INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Richard S Levy: EVP, Chief Drug Dev Officer, EVP, Chief Drug Dev&Medical Of
Holdings: 16,926 shares
Current Value: $2,000,315
Latest Transaction: Jan 08 2016
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Richard S Levy in INCYTE CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNST, INCY, KNSA, KOD, SNTA, TARA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2016 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 2,876 | |
| Jan 08 2016 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 101.86 | 3,937 | 401,023 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
| Jan 08 2016 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 20,863 | 16.9 K to 20.9 K (+23.26 %) |
| Dec 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 6,813 | |
| Dec 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 106.18 | 3,937 | 418,031 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
| Dec 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 20,863 | 16.9 K to 20.9 K (+23.26 %) |
| Nov 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,936 | 72,108 | 10,750 | |
| Nov 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 116.51 | 3,936 | 458,583 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
| Nov 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,936 | 72,108 | 20,862 | 16.9 K to 20.9 K (+23.25 %) |
| Oct 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 14,686 | |
| Oct 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 122.29 | 3,937 | 481,456 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
| Oct 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 20,863 | 16.9 K to 20.9 K (+23.26 %) |
| Sep 15 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 130.00 | 4,301 | 559,130 | 16,926 | 21.2 K to 16.9 K (-20.26 %) |
| Sep 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 18,623 | |
| Sep 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 118.90 | 3,937 | 468,109 | 21,227 | 25.2 K to 21.2 K (-15.65 %) |
| Sep 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 25,164 | 21.2 K to 25.2 K (+18.55 %) |
| Aug 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,936 | 72,108 | 22,560 | |
| Aug 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 111.95 | 3,936 | 440,635 | 21,227 | 25.2 K to 21.2 K (-15.64 %) |
| Aug 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,936 | 72,108 | 25,163 | 21.2 K to 25.2 K (+18.54 %) |
| Jul 16 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 17.79 | 70,217 | 1,249,160 | 0 | |
| Jul 16 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 120.00 | 70,217 | 8,426,040 | 21,227 | 91.4 K to 21.2 K (-76.79 %) |
| Jul 16 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 17.79 | 70,217 | 1,249,160 | 91,444 | 21.2 K to 91.4 K (+330.79 %) |
| Jul 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 26,496 | |
| Jul 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 107.00 | 3,937 | 421,259 | 21,227 | 25.2 K to 21.2 K (-15.65 %) |
| Jul 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 25,164 | 21.2 K to 25.2 K (+18.55 %) |
| Jun 23 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 17.79 | 20,000 | 355,800 | 70,217 | |
| Jun 23 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 108.13 | 20,000 | 2,162,600 | 21,227 | 41.2 K to 21.2 K (-48.51 %) |
| Jun 23 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 17.79 | 20,000 | 355,800 | 41,227 | 21.2 K to 41.2 K (+94.22 %) |
| Jun 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 30,433 | |
| Jun 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 107.58 | 3,937 | 423,542 | 21,227 | 25.2 K to 21.2 K (-15.65 %) |
| Jun 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 25,164 | 21.2 K to 25.2 K (+18.55 %) |
| May 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 7,412 | 135,788 | 34,370 | |
| May 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 99.43 | 7,412 | 736,975 | 21,227 | 28.6 K to 21.2 K (-25.88 %) |
| May 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 7,412 | 135,788 | 28,639 | 21.2 K to 28.6 K (+34.92 %) |
| Apr 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 25,000 | 458,000 | 41,782 | |
| Apr 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 88.77 | 25,000 | 2,219,250 | 21,227 | 46.2 K to 21.2 K (-54.08 %) |
| Apr 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 25,000 | 458,000 | 46,227 | 21.2 K to 46.2 K (+117.77 %) |
| Mar 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 25,000 | 458,000 | 66,782 | |
| Mar 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 89.91 | 25,000 | 2,247,750 | 21,227 | 46.2 K to 21.2 K (-54.08 %) |
| Mar 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 25,000 | 458,000 | 46,227 | 21.2 K to 46.2 K (+117.77 %) |
| Oct 24 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 3.11 | 13,904 | 43,241 | 0 | |
| Oct 24 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 3.11 | 13,904 | 43,241 | 18,205 | 4.3 K to 18.2 K (+323.27 %) |
| Oct 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 44,317 | |
| Oct 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 49.03 | 8,000 | 392,240 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
| Oct 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
| Sep 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 52,317 | |
| Sep 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 47.58 | 8,000 | 380,640 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
| Sep 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
| Aug 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 60,317 | |
| Aug 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 51.97 | 8,000 | 415,760 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
| Aug 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
| Jul 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 68,317 | |
| Jul 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 48.15 | 8,000 | 385,200 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
| Jul 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
| Jun 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 76,317 | |
| Jun 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 53.88 | 8,000 | 431,040 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
| Jun 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
| May 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 84,317 | |
| May 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 50.68 | 8,000 | 405,440 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
| May 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 13.34 | 417 | 5,563 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 13.34 | 14,583 | 194,537 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 24,787 | 233,246 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 1,945 | 23,301 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 9,138 | 109,473 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 12,300 | 115,743 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 25,862 | 309,827 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 47,913 | 450,861 | 24,787 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 3.11 | 61,096 | 190,009 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 33,055 | 395,999 | 0 | |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 66.13 | 39,787 | 2,631,114 | 4,301 | 44.1 K to 4.3 K (-90.24 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 13.34 | 417 | 5,563 | 44,088 | 43.7 K to 44.1 K (+0.95 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 13.34 | 14,583 | 194,537 | 43,671 | 29.1 K to 43.7 K (+50.13 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 24,787 | 233,246 | 29,088 | 4.3 K to 29.1 K (+576.31 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 66.38 | 191,309 | 12,699,091 | 4,301 | 195.6 K to 4.3 K (-97.80 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 1,945 | 23,301 | 195,610 | 193.7 K to 195.6 K (+1.00 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 9,138 | 109,473 | 193,665 | 184.5 K to 193.7 K (+4.95 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 12,300 | 115,743 | 184,527 | 172.2 K to 184.5 K (+7.14 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 25,862 | 309,827 | 172,227 | 146.4 K to 172.2 K (+17.67 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 47,913 | 450,861 | 146,365 | 98.5 K to 146.4 K (+48.67 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 3.11 | 61,096 | 190,009 | 98,452 | 37.4 K to 98.5 K (+163.55 %) |
| Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 33,055 | 395,999 | 37,356 | 4.3 K to 37.4 K (+768.54 %) |
| Jan 23 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 64.55 | 34,868 | 2,250,729 | 34,868 | |
| Jan 23 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 64.55 | 997 | 64,356 | 997 | |
| Sep 09 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 25,000 | 299,500 | 862 | |
| Sep 09 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 35.28 | 25,000 | 882,000 | 0 | 25 K to 0 (-100.00 %) |
| Sep 09 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 25,000 | 299,500 | 25,000 | 0 to 25 K |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 7.09 | 4,301 | 30,494 | 0 | |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 7.09 | 55,699 | 394,906 | 0 | |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 22.30 | 55,699 | 1,242,088 | 4,301 | 60 K to 4.3 K (-92.83 %) |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 7.09 | 4,301 | 30,494 | 60,000 | 55.7 K to 60 K (+7.72 %) |
| May 15 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 7.09 | 55,699 | 394,906 | 55,699 | 0 to 55.7 K |
| Feb 20 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 8.99 | 38,440 | 345,576 | 0 | |
| Feb 20 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 5.46 | 16,251 | 88,730 | 0 | |
| Feb 20 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 5.46 | 43,749 | 238,870 | 0 | |
| Feb 20 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 22.48 | 98,440 | 2,212,931 | 0 | 98.4 K to 0 (-100.00 %) |
| Feb 20 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 8.99 | 38,440 | 345,576 | 98,440 | 60 K to 98.4 K (+64.07 %) |
| Feb 20 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 5.46 | 16,251 | 88,730 | 60,000 | 43.7 K to 60 K (+37.15 %) |
| Feb 20 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 5.46 | 43,749 | 238,870 | 43,749 | 0 to 43.7 K |
| Feb 12 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 18.32 | 141,782 | 2,597,446 | 141,782 | |
| Feb 12 2013 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 18.32 | 8,218 | 150,554 | 8,218 | |
| May 01 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 8.19 | 8,440 | 69,124 | 0 | |
| May 01 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 8.99 | 9,751 | 87,661 | 38,440 | |
| May 01 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 8.99 | 11,809 | 106,163 | 0 | |
| May 01 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 22.95 | 30,000 | 688,500 | 0 | 30 K to 0 (-100.00 %) |
| May 01 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 8.19 | 8,440 | 69,124 | 30,000 | 21.6 K to 30 K (+39.15 %) |
| May 01 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 8.99 | 9,751 | 87,661 | 21,560 | 11.8 K to 21.6 K (+82.57 %) |
| May 01 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 8.99 | 11,809 | 106,163 | 11,809 | 0 to 11.8 K |
| Jan 23 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 17.79 | 93,900 | 1,670,481 | 93,900 | |
| Jan 23 2012 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 17.79 | 6,100 | 108,519 | 6,100 | |
| Jan 27 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 14.72 | 92,317 | 1,358,906 | 92,317 | |
| Jan 27 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 14.72 | 7,683 | 113,094 | 7,683 | |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 8.19 | 25,310 | 207,289 | 0 | |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 4.19 | 15,000 | 62,850 | 0 | |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.77 | 6,400 | 100,928 | 0 | 6.4 K to 0 (-100.00 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.79 | 10,000 | 157,900 | 6,400 | 16.4 K to 6.4 K (-60.98 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.80 | 13,600 | 214,880 | 16,400 | 30 K to 16.4 K (-45.33 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.81 | 8,200 | 129,642 | 30,000 | 38.2 K to 30 K (-21.47 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.82 | 1,494 | 23,635 | 38,200 | 39.7 K to 38.2 K (-3.76 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 16.01 | 616 | 9,862 | 39,694 | 40.3 K to 39.7 K (-1.53 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 8.19 | 25,310 | 207,289 | 40,310 | 15 K to 40.3 K (+168.73 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 4.19 | 15,000 | 62,850 | 15,000 | 0 to 15 K |
| May 20 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 4.19 | 20,000 | 83,800 | 15,000 | |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 12.94 | 20,000 | 258,800 | 0 | 20 K to 0 (-100.00 %) |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 4.19 | 20,000 | 83,800 | 20,000 | 0 to 20 K |
| Jan 25 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 9.41 | 72,700 | 684,107 | 72,700 | |
| Jan 25 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 9.41 | 12,300 | 115,743 | 12,300 | |
| Jan 29 2009 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 3.11 | 61,096 | 190,009 | 61,096 | |
| Jan 29 2009 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 3.11 | 13,904 | 43,241 | 13,904 |
Page: 1